Frontiers Health 2024: Day One
Welcome to our live coverage of Frontiers Health 2024 - Day One!
Frontiers Health 2024 Live Coverage
Frontiers Health is back, bringing together healthcare innovators from around the world to exchange insights and discuss the hottest healthcare trends
NICE backs first targeted therapy for ALK+ lung cancer
Roche's Alecensa has been recommended for routine NHS use as an adjuvant treatment for ALK-positive non-small cell lung cancer (NSCLC), the first targeted therapy for this indication.
Australia joins EU in turning down Alzheimer's drug Leqembi
Australia's Therapeutic Goods Administration (TGA) has said it won't approve Eisai and Biogen's Alzheimer's disease therapy Leqembi, saying its efficacy does not outweigh its risks.
First human skin atlas points way to healing without scars
Researchers have created a map of human skin that uses genomics and other technologies to understand how skin forms and the mechanisms behind skin disorders.
Featured Content
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
BIO-Europe's 30th Anniversary Landmark Event in Stockholm
BIO-Europe™ celebrates 30 years of facilitating partnerships this Fall. In 1994, BIO-Europe launched with the mission to drive biotech innovation and
8th Dermatology Drug Development Summit
Industry’s Destination to Discover & Develop Best-In-Class Drugs for Immuno-Inflammatory Skin Disease
7th RNA-Targeted Drug Discovery & Development Summit
Optimizing Lead Discovery, Structural Analysis & Preclinical Modeling to Successfully Develop Stable, Effective & Orally Bioavailable Small Molecule RNA Drugs for Robust Translation
9th CDD For Biologics Summit 2024
Integrate Computational Biology, Generative AI & Machine Learning to Revolutionize Biologics Drug Discovery & Development
Targeted Radiopharmaceuticals Summit EU 2024
Taking place in Amsterdam 3rd- 5th December! With 40+ new speakers, 2 tracks of content (pre-clinical and clinical), a deep dive workshop day